"Development of a DC-SIGN targeting integration deficient lentiviral vector for therapeutic vaccination in cancer and chronic infectious disease" by Dr Jan ter Meulen

Past Event

20 March 2014, 12:00pm - 1:00pm


This seminar is hosted by the Oxford Martin Programme on Vaccines and the Jenner Institute

Speaker: Jan ter Meulen, MD, Dr.habil., DTM&H, Chief Scientific Officer, ImmuneDesign

Venue: Seminar Room, NDM Research Building